International study finds increased mortality in adults with Down syndrome

by Centre for Genomic Regulation

​Research led by King’s College London in collaboration with the Centre for Genomic Regulation (CRG) and the Trisomy 21 Research Society (T21RS) finds increased COVID-19 mortality among adults wit...

Read more

Connecta Therapeutics raises €1.7 M in a round led by Inveready to develop new treatment for fragile X syndrome

by Inveready

Connecta Therapeutics has closed a €1.7 million round of investment led by Inveready that will allow the company to take its first drug through to phase IIa clinical trials in patients who have frag...

Read more

Down syndrome in Europe – has the disease epidemiology changed over the last quarter-century?

by European Commission - Joint Research Centre

Of the 5.2 million births in the European Union (EU) each year, approximately 104,000 (2.5%) will be born with congenital anomalies.

Read more

Major international project aims to identify causes of dementia

by Centre for Genomic Regulation

European scientists have launched a research programme, which aims to identify common causes of dementia in Alzheimer’s Disease, Parkinson’s Disease and Down Syndrome. The project brings together...

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

More than 6% of Europeans suffer from de...

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

A study in 27 European countries led by researchers from King’s Coll...

Photos Stream